Real-time SEC alerts Start Free →
Profitelligence
Agilent Technologies Inc.
A HIGH Impact

Agilent Technologies Inc.

Agilent Announces CFO Transition

| 8-K |Healthcare

Summary

On July 11, 2025, Agilent Technologies, Inc. announced the resignation of its Chief Financial Officer, Robert W. McMahon, effective July 31, 2025. Rodney Gonsalves, Agilent's current corporate controller, has been appointed as interim CFO. The company also disclosed this transition under Regulation FD on July 15, 2025.

Profitelligence Profitelligence Alerts

Get alerts for A

Be first to know when Agilent Technologies Inc. files with the SEC.

Set Up Alerts →

Filing Categories

CFO Resignation New CFO Appointed Regulation FD Disclosure Exhibits Furnished

Exhibits (1)

Advertisement

About Agilent Technologies Inc.

Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.

Exchange: NYSE Industry: Diagnostics & Research Company Website →

Official SEC Documents

A
A Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement